Lantheus Holdings (LNTH) EBITDA Margin Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 255.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 255.00 |
| Mar 31, 2026 | -583.00 |
| Dec 31, 2025 | -1,014.00 |
| Sep 30, 2025 | -2,396.00 |
| Jun 30, 2025 | -280.00 |
| Mar 31, 2025 | -144.00 |
| Dec 31, 2024 | -88,746.00 |
| Sep 30, 2024 | 19.00 |
| Jun 30, 2024 | -1,252.00 |
| Mar 31, 2024 | 3,193.00 |
| Dec 31, 2023 | 98,181.00 |
| Sep 30, 2023 | -71.00 |
| Jun 30, 2023 | 1,034.00 |
| Mar 31, 2023 | -3,132.00 |
| Dec 31, 2022 | -3,796.00 |
| Sep 30, 2022 | 4,987.00 |
| Jun 30, 2022 | 5,475.00 |
| Mar 31, 2022 | 1,132.00 |
| Dec 31, 2021 | -2,671.00 |
| Sep 30, 2021 | -811.00 |